Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity
Saved in:
| Published in: | Endocrinology, Diabetes & Metabolism Case Reports |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553118392778752 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Endocrinology, Diabetes & Metabolism Case Reports |
| description | |
| discipline_display | Endocrinology |
| discipline_facet | Endocrinology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:73771 |
| institution | FRELIP |
| journal_source_facet | Endocrinology, Diabetes & Metabolism Case Reports |
| last_indexed | 2026-06-20T21:31:51.751Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity Endocrinology General Endocrinology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Endocrinology General Endocrinology |
| subject_facet | Endocrinology General Endocrinology |
| title | Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity |
| title_alt | Tirzepatida redujo el consumo de alcohol en tres pacientes con enfermedad hepática asociada al alcohol, diabetes tipo 2 y obesidad Le tirzépatide a réduit la consommation d'alcool chez trois patients atteints de maladie hépatique liée à l'alcool, de diabète de type 2 et d'obésité Tirzepatida reduziu o uso de álcool em três pacientes com doença hepática associada ao álcool, diabetes tipo 2 e obesidade |
| title_auth | Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity |
| title_es_txt | Tirzepatida redujo el consumo de alcohol en tres pacientes con enfermedad hepática asociada al alcohol, diabetes tipo 2 y obesidad |
| title_fr_txt | Le tirzépatide a réduit la consommation d'alcool chez trois patients atteints de maladie hépatique liée à l'alcool, de diabète de type 2 et d'obésité |
| title_full | Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity |
| title_fullStr | Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity |
| title_full_unstemmed | Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity |
| title_pt_txt | Tirzepatida reduziu o uso de álcool em três pacientes com doença hepática associada ao álcool, diabetes tipo 2 e obesidade |
| title_short | Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity |
| title_sort | tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity |
| topic | Endocrinology General Endocrinology |
| url | https://edm.bioscientifica.com/view/journals/edm/2026/2/EDM-26-0002.xml |